The LINC00460/DHX9/IGF2BP2 complex promotes CRC proliferation and metastasis by m6A modification, which could serve as a promising predictive biomarker for the diagnosis and prognosis (Hou et al., 2021). Here, IGF2BP2 is linked to colorectal carcinoma.